Krajina: Spojené štáty
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
fluocinolone acetonide (UNII: 0CD5FD6S2M) (fluocinolone acetonide - UNII:0CD5FD6S2M)
Royal Pharmaceuticals
fluocinolone acetonide
fluocinolone acetonide 0.11 mg in 1 mL
AURICULAR (OTIC)
PRESCRIPTION DRUG
DermOtic® Oil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. This product contains refined peanut oil NF (See PRECAUTIONS).
DermOtic® Oil (fluocinolone acetonide oil) 0.01% Ear Drops is supplied in 1 fluid ounce bottles containing 20 mL, net content (Dropper Included) (NDC # 68791-103-20). Keep tightly closed. Store at 20°-25° C (68° to 77° F); excursions permitted to 15°-30° C (59°-86°F.)[see USP Controlled Room Temperature]. Discard DermOtic Oil 2 months after initial use. Keep tightly closed. Store at 20°-25° C (68° to 77° F); excursions permitted to 15°-30° C (59°-86°F.) [see USP Controlled Room Temperature]. CAUTION: Rx only
New Drug Application
DERMOTIC- FLUOCINOLONE ACETONIDE OIL ROYAL PHARMACEUTICALS ---------- DERMOTIC OIL (FLUOCINOLONE ACETONIDE OIL) 0.01% EAR DROPS For Otic Use Only- Not for Ophthalmic Use NDC 68791-103-20 DESCRIPTION DermOtic Oil Ear Drops contain fluocinolone acetonide {(6α, 11β, 16α)-6,9-difluoro- 11,21-dihydroxy-16,17[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione, cyclic 16,17 acetal with acetone}, a synthetic corticosteroid. This formulation is also marketed as Derma-Smoothe/FS Body Oil for the treatment of atopic dermatitis and Derma-Smoothe/FS Scalp Oil for the treatment of psoriasis of the scalp. Chemically, fluocinolone acetonide is C H F O . It has the following structural formula: ® ® ® ® 24 30 2 6 ® Fluocinolone acetonide in DermOtic Oil has a molecular weight of 452.50. It is a white crystalline powder that is odorless, stable in light, and melts at 270°C with decomposition; soluble in alcohol, acetone and methanol; slightly soluble in chloroform; insoluble in water. Each gram of DermOtic Oil contains approximately 0.11 mg of fluocinolone acetonide in a blend of oils, which contains isopropyl alcohol, isopropyl myristate, light mineral oil, oleth-2, refined peanut oil NF and fragrances. CLINICAL PHARMACOLOGY Like other topical corticosteroids, fluocinolone acetonide has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A . PHARMACOKINETICS The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the Prečítajte si celý dokument